Cardiovascular Risk Assessment Models: Have We Found the Perfect Solution Yet?

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2019 Feb 23

PMID 30793251

Citations 5

Authors

Aiden Abidov

Omar Chehab

Affiliations

Soon will be listed here.

Citing Articles

Socioeconomic status as a potential mediator of arterial aging in marginalized ethnic and racial groups: current understandings and future directions.

Darvish S, Mahoney S, Venkatasubramanian R, Rossman M, Clayton Z, Murray K J Appl Physiol (1985). 2024; 137(1):194-222.

PMID: 38813611 PMC: 11389897. DOI: 10.1152/japplphysiol.00188.2024.

Knowledge, awareness, and attitude among pharmacists regarding the risk estimation of cardiovascular disease in Jordan: Immersion of lipid-lowering agents.

Rababah A, Ababneh M, Abedalqader N, Altarabsheh S Heliyon. 2023; 9(9):e19288.

PMID: 37674836 PMC: 10477471. DOI: 10.1016/j.heliyon.2023.e19288.

Recommendations for statin management in primary prevention: disparities among international risk scores.

Mancini G, Ryomoto A, Yeoh E, Brunham L, Hegele R Eur Heart J. 2023; 45(2):117-128.

PMID: 37638490 PMC: 10771376. DOI: 10.1093/eurheartj/ehad539.

Identifying Cardiovascular Risk Profiles Clusters among Mediterranean Adolescents across Seven Countries.

Tesler R, Barak S, Reges O, Moreno-Maldonado C, Maor R, Gaspar T Healthcare (Basel). 2022; 10(2).

PMID: 35206882 PMC: 8872068. DOI: 10.3390/healthcare10020268.

Estimated cost for cardiovascular disease risk-based management at a primary healthcare center in Nepal.

Aryal A, Citrin D, Halliday S, Kumar A, Nepal P, Shrestha A Glob Health Res Policy. 2020; 5:2.

PMID: 32016159 PMC: 6988194. DOI: 10.1186/s41256-020-0130-2.

References

Benjamin E, Virani S, Callaway C, Chamberlain A, Chang A, Cheng S . Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018; 137(12):e67-e492. DOI: 10.1161/CIR.0000000000000558. View

Frohlich E, Quinlan P . Coronary heart disease risk factors: public impact of initial and later-announced risks. Ochsner J. 2015; 14(4):532-7. PMC: 4295729. View

Willadsen T, Bebe A, Koster-Rasmussen R, Jarbol D, Guassora A, Waldorff F . The role of diseases, risk factors and symptoms in the definition of multimorbidity - a systematic review. Scand J Prim Health Care. 2016; 34(2):112-21. PMC: 4977932. DOI: 10.3109/02813432.2016.1153242. View

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F . Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364(9438):937-52. DOI: 10.1016/S0140-6736(04)17018-9. View

Hobbs F, Jukema J, da Silva P, McCormack T, Catapano A . Barriers to cardiovascular disease risk scoring and primary prevention in Europe. QJM. 2010; 103(10):727-39. DOI: 10.1093/qjmed/hcq122. View

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R . European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by.... Eur J Cardiovasc Prev Rehabil. 2007; 14 Suppl 2:S1-113. DOI: 10.1097/01.hjr.0000277983.23934.c9. View

Chaturvedi N . Ethnic differences in cardiovascular disease. Heart. 2003; 89(6):681-6. PMC: 1767706. DOI: 10.1136/heart.89.6.681. View

Kurian A, Cardarelli K . Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007; 17(1):143-52. View

Gilstrap L, Wang T . Biomarkers and cardiovascular risk assessment for primary prevention: an update. Clin Chem. 2011; 58(1):72-82. PMC: 4105324. DOI: 10.1373/clinchem.2011.165712. View

10.

Vasan R . Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation. 2006; 113(19):2335-62. DOI: 10.1161/CIRCULATIONAHA.104.482570. View

11.

Jin J . Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors. JAMA. 2018; 320(3):316. DOI: 10.1001/jama.2018.9122. View

12.

Bonner C, Fajardo M, Hui S, Stubbs R, Trevena L . Clinical Validity, Understandability, and Actionability of Online Cardiovascular Disease Risk Calculators: Systematic Review. J Med Internet Res. 2018; 20(2):e29. PMC: 5814602. DOI: 10.2196/jmir.8538. View

13.

Naghavi M, Falk E, Hecht H, Jamieson M, Kaul S, Berman D . From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006; 98(2A):2H-15H. DOI: 10.1016/j.amjcard.2006.03.002. View

14.

Shaw L, Eisenstein E, Hachamovitch R, Heller G, Miller D . A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II. J Nucl Cardiol. 1997; 4(1 Pt 1):52-60. DOI: 10.1016/s1071-3581(97)90049-0. View

15.

Shaw L, Hachamovitch R, Eisenstein E, Kesler K, Heller G, Miller D . A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part I. J Nucl Cardiol. 1996; 3(6 Pt 1):538-45. DOI: 10.1016/s1071-3581(96)90062-8. View

16.

Abidov A, Raff G . Value of coronary CTA in patients with known or suspected CAD and non-diagnostic initial myocardial perfusion testing: current evidence and clinical considerations. J Nucl Cardiol. 2010; 17(6):1101-6. DOI: 10.1007/s12350-010-9294-3. View

17.

Martineau P, Slomka P, Goertzen A, Leslie W . CRAX: A simple cardiovascular risk assessment tool to predict risk of acute myocardial infarction or death. J Nucl Cardiol. 2018; 27(6):2365-2374. PMC: 6565497. DOI: 10.1007/s12350-018-01556-0. View

18.

Betancur J, Otaki Y, Motwani M, Fish M, Lemley M, Dey D . Prognostic Value of Combined Clinical and Myocardial Perfusion Imaging Data Using Machine Learning. JACC Cardiovasc Imaging. 2017; 11(7):1000-1009. PMC: 5902657. DOI: 10.1016/j.jcmg.2017.07.024. View

19.

Koh A, Gao F, Chin C, Keng F, Tan R, Chua T . Differential risk reclassification improvement by exercise testing and myocardial perfusion imaging in patients with suspected and known coronary artery disease. J Nucl Cardiol. 2015; 23(3):366-78. DOI: 10.1007/s12350-015-0253-x. View

20.

Shaw L, Wilson P, Hachamovitch R, Hendel R, Borges-Neto S, Berman D . Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT. JACC Cardiovasc Imaging. 2010; 3(11):1139-48. DOI: 10.1016/j.jcmg.2010.09.008. View